EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of Contextual-Level Social Determinants of Health on Newer Antidiabetic Drug Adoption in Patients with Type 2 Diabetes

Yujia Li iD, Hui Hu iD, Yi Zheng, William Troy Donahoo iD, Yi Guo iD, Jie Xu iD, Wei-Han Chen iD, Ning Liu, Elisabeth A Shenkman, Jiang Bian iD, Jingchuan Guo iD

International Journal of Environmental Research and Public Health · 2023

DOI: 10.3390/ijerph20054036 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Environmental Research and Public Health, 2023. Verfasst von Yujia Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Florida, Gainesville, FL 32610, USA. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Hypoglycemic Agents, Social Determinants of Health, Sodium-Glucose Transporter 2 Inhibitors. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIH NIDDK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

We aimed to investigate the association between contextual-level social determinants of health (SDoH) and the use of novel antidiabetic drugs (ADD), including sodium-glucose cotransporter-2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP1a) for patients with type 2 diabetes (T2D), and whether the association varies across racial and ethnic groups.

Methods

Using electronic health records from the OneFlorida+ network, we assembled a cohort of T2D patients who initiated a second-line ADD in 2015–2020. A set of 81 contextual-level SDoH documenting social and built environment were spatiotemporally linked to individuals based on their residential histories. We assessed the association between the contextual-level SDoH and initiation of SGTL2i/GLP1a and determined their effects across racial groups, adjusting for clinical factors.

Results

Of 28,874 individuals, 61% were women, and the mean age was 58 (±15) years. Two contextual-level SDoH factors identified as significantly associated with SGLT2i/GLP1a use were neighborhood deprivation index (odds ratio [OR] 0.87, 95% confidence interval [CI] 0.81–0.94) and the percent of vacant addresses in the neighborhood (OR 0.91, 95% CI 0.85–0.98). Patients living in such neighborhoods are less likely to be prescribed with newer ADD. There was no interaction between race-ethnicity and SDoH on the use of newer ADD. However, in the overall cohort, the non-Hispanic Black individuals were less likely to use newer ADD than the non-Hispanic White individuals (OR 0.82, 95% CI 0.76–0.88).

Conclusion

Using a data-driven approach, we identified the key contextual-level SDoH factors associated with not following evidence-based treatment of T2D. Further investigations are needed to examine the mechanisms underlying these associations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Hypoglycemic AgentsSocial Determinants of HealthSodium-Glucose Transporter 2 InhibitorsFemaleHumansMaleMiddle AgedWhite PeopleAdultAgedBlack People

Stichwörter der Autor:innen

antidiabetic drugsneighborhood deprivation indexsocial determinants of healthtype 2 diabetesvacant land

Substanzen

Hypoglycemic AgentsSodium-Glucose Transporter 2 Inhibitors

Autor:innen und Institutionen

  • Department of Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Florida, Gainesville, FL 32610, USA.
  • Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA.
  • Department of Medicine, Harvard Medical School, Boston, MA 02115, USA.
  • Division of Endocrinology, Diabetes and Metabolism, College of Medicine, University of Florida, Gainesville, FL 32610, USA.
  • Department of Health Outcomes & Biomedical Informatics, College of Medicine, University of Florida, Gainesville, FL 32610, USA.

ORCID-Profile: Yujia Li, Hui Hu, William Troy Donahoo, Yi Guo, Jie Xu, Wei-Han Chen, Jiang Bian, Jingchuan Guo

Förderung

  • NIDDK NIH HHS
  • NIH NIDDK

Zitieren

APA

Li, Y., Hu, H., Zheng, Y., Donahoo, W. T., Guo, Y., Xu, J., Chen, W. H., Liu, N., Shenkman, E. A., Bian, J., & Guo, J. (2023). Impact of Contextual-Level Social Determinants of Health on Newer Antidiabetic Drug Adoption in Patients with Type 2 Diabetes. International Journal of Environmental Research and Public Health. https://doi.org/10.3390/ijerph20054036

Vancouver

Li Y, Hu H, Zheng Y, Donahoo WT, Guo Y, Xu J, et al. Impact of Contextual-Level Social Determinants of Health on Newer Antidiabetic Drug Adoption in Patients with Type 2 Diabetes. International Journal of Environmental Research and Public Health. 2023. doi:10.3390/ijerph20054036

BibTeX
@article{Li2023,
  author = {Li, Yujia and Hu, Hui and Zheng, Yi and Donahoo, William Troy and Guo, Yi and Xu, Jie and Chen, Wei-Han and Liu, Ning and Shenkman, Elisabeth A and Bian, Jiang and Guo, Jingchuan},
  title = {Impact of Contextual-Level Social Determinants of Health on Newer Antidiabetic Drug Adoption in Patients with Type 2 Diabetes},
  journal = {International Journal of Environmental Research and Public Health},
  year = {2023},
  doi = {10.3390/ijerph20054036}
}
Kostenlos starten →